News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
I don’t understand people who are stingy with co-authorship – Prof Dynarski
Photo of Prof Dynarski from gse.harvard.edu
Aug 8, 2023, 19:53

I don’t understand people who are stingy with co-authorship – Prof Dynarski

I don’t understand people who are stingy with co-authorship

Especially for grad students and junior faculty

Sharing credit reflects well on you as an advisor, mentor, person

BONUS!

when they become stars you get their reflected glory

Source: Prof Dynarski / Twitter

cancer co-authorship mentor OncoDaily Oncology Prof Dynarski stingy
Special Coverage
Blog
Nov 2, 2024, 21:41
Abstract submission open for the AACR Annual Meeting 2025
Insight
Nov 2, 2024, 21:32
Shushan Hovsepyan: Are we overestimating the true benefits of cancer drugs?
Blog
Nov 2, 2024, 21:31
The ACHO Defying Cancer Award competition is open - Conquer Cancer, the ASCO Foundation
Insight
Nov 2, 2024, 21:28
Yan Leyfman: Inavolisib with palbociclib–fulvestrant for PIK3CA-mutated, HR+, HER2- breast cancer
Blog
Nov 2, 2024, 21:25
SIOPE and CCI-E Children's Rights Day event
Blog
Nov 2, 2024, 21:22
Nikolas Politis during his fellowship at the Champalimaud Clinical Centre - European School of Oncology
Blog
Nov 2, 2024, 21:19
Yin Ling Woo: A big boost for the third pillar of cervical cancer elimination
Blog
Nov 2, 2024, 21:18
Aachal Bajaj: Be so passionate about what you do that work doesn’t feel like work
Insight
Nov 2, 2024, 21:09
Equality, Diversity, and Inclusion in IJGC - European Society of Gynaecological Oncology
Insight
Nov 2, 2024, 21:06
Sabine Brookman-May: Are pre-treatment biopsies the way to go in mUC?
Insight
Nov 2, 2024, 20:53
Anand Patel: Therapy-related myeloid neoplasms review by Sangeetha Venugopal and Amy DeZern
Insight
Nov 2, 2024, 20:51
Daniel Shapiro: Our editorial regarding perioperative trials in RCC